Designing clinical trials to improve neurobehavioral outcome after traumatic brain injury: From bench to bedside

Critical Care Medicine

Volumn 37, Issue 2, 2009, Pages 784-785

  Arciniegas, David B ^a,b  

^a HealthONE Spalding Rehabilitation Hospital   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trials; Memory; Neurobehavioral function; Outcome; Traumatic brain injury

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CANNABINOID DERIVATIVE; COMPLEMENT COMPONENT C1S INHIBITOR; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROGESTERONE; STEROID;

BRAIN INJURY; CLINICAL TRIAL; COGNITIVE DEFECT; EDITORIAL; EXPERIMENTAL ANIMAL; FAMILY; HUMAN; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL RATE; TRAUMATIC BRAIN INJURY;

BRAIN INJURIES; CLINICAL TRIALS AS TOPIC; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RESEARCH DESIGN;

EID: 67650355429     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181959e46     Document Type: Editorial

References (15)

1. Gabriel EJ, Ghajar J, Jagoda A, et al: Brain Trauma Foundation: Guidelines for prehos-pital managment of traumatic brain injury. J Neurotrauma 2002; 19:111-174
2. Marion DW: Evidenced-based guidelines for traumatic brain injuries. Prog Neurol Surg 2006; 19:171-196
3. Thurman D, Guerrero J: Trends in hospital-ization associated with traumatic brain injury. JAMA 1999; 282:954-957
4. Zaloshnja E, Miller E, Langlois JA, Selassie AW: Prevalence of long-term disability from traumatic brain injury in the civilian population of the United States, 2005. J Head Trauma Rehabil 2008; 23:394-400
5. Beauchamp K, Mutlak H, Smith WR, et al: Pharmacology of traumatic brain injury: Where is the "golden bullet"? Mol Med 2008; 14:731-740
6. Maas AI, Marmarou A, Murray GD, et al: Prognosis and clinical trial design in traumatic brain injury: The IMPACT study. J Neurotrauma 2007; 24:232-238
7. Jennett B, Bond M: Assessment of outcome after severe brain damage. Lancet 1975; 1:480-484
8. Levin HS: Neurobehavioral outcome of closed head injury: Implications for clinical trials. J Neurotrauma 1995; 12:601-610
9. Levin HS, Gary HE Jr, Eisenberg HM, et al: Neurobehavioral outcome 1 year after severe head injury. Experience of the Traumatic Coma Data Bank. J Neurosurg 1990; 73: 699-709
10. Dikmen S, Machamer J, Miller B, et al: Functional status examination: A new instrument for assessing outcome in traumatic brain injury. J Neurotrauma 2001; 18:127-140
11. Hall KM, Bushnik T, Lakisic-Kazazic B, et al: Assessing traumatic brain injury outcome measures for long-term follow-up of community-based individuals. Arch Phys Med Rehabil 2001; 82:367-374
12. Dikmen SS, Machamer JE, Powell JM, et al: Outcome 3 to 5 years after moderate to severe traumatic brain injury. Arch Phys Med Rehabil 2003; 84:1449-1457
13. Groom KN, Shaw TG, O'Connor ME, et al: Neurobehavioral symptoms and family functioning in traumatically brain-injured adults. Arch Clin Neuropsychol 1998; 13:695-711
14. Anderson CA, Arciniegas DB, Filley CM: Treatment of acute ischemic stroke: Does it impact neuropsychiatric outcome? J Neuropsychiatry Clin Neurosci 2005; 17:486-488
15. Longhi L, Perego C, Ortolano F, et al: C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice. Crit Care Med 2009; 37:659-665